Clinical Trials Browser

Interventional × Celecoxib × Breast × Clear all

NCT01881048 2026-01-29

Window of Opportunity Study Targeting the Inflammatory Milieu

Phase EARLY_PHASE1 Completed

Breast Neoplasms

NCT07104266 2025-08-05

Triple Negative Breast Cancer and Celecoxib. Pilot Study

Phase 2 Recruiting

Triple Negative Breast Neoplasms

NCT05756166 2025-06-24

Rintatolimod, Celecoxib and Interferon Alpha 2b With Pembrolizumab For the Treatment of Patients With Metastatic or Unresectable Triple Negative Breast Cancer

Phase 1/2 Terminated

Triple Negative Breast Neoplasms

NCT03084536 2024-12-24

PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery

Phase 2 Completed

134 enrolled 9 charts

Breast Neoplasms

NCT03878524 2024-03-04

Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial

Phase 1 Terminated

BreastClassical hematologyGastrointestinalGenitourinaryLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Blast Crisis, Breast Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neoplasm Metastasis, Pancreatic Neoplasms, Prostatic Neoplasms, Thrombocytosis, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

NCT00665457 2023-09-13

Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery

Phase 2 Terminated

3 enrolled 6 charts

Breast Neoplasms

NCT04081389 2023-09-11

Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast Cancer

Phase 1 Completed

9 enrolled 17 charts

Breast Carcinoma In Situ, Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03599453 2023-07-18

Chemokine Modulation Therapy and Pembrolizumab in Treating Participants With Metastatic Triple-Negative Breast Cancer

Phase EARLY_PHASE1 Completed

Triple Negative Breast Neoplasms

NCT00075673 2020-07-27

Vinorelbine and Celecoxib in Treating Women With Relapsed or Metastatic Breast Cancer

Phase 1 Terminated

Breast Neoplasms

NCT02429427 2020-06-23

REACT

Phase 3 Completed

2,639 enrolled 12 charts

Breast Neoplasms

NCT03185871 2019-11-15

Celecoxib Window of Opportunity Trial to Assess Tumor and Stroma Responses

Phase 2 Withdrawn

Breast Neoplasms

NCT00088972 2018-08-10

S0300, Celecoxib in Preventing Breast Cancer in Premenopausal Women

Phase 2 Terminated

8 enrolled 5 charts

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Ductal, Breast

NCT01695226 2018-01-09

Randomized Controlled Phase II Trial of Pre-operative Celecoxib Treatment in Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT01425476 2017-08-09

Changes in Breast Cancer Biomarkers Using Synergistic Prostaglandin Inhibitors

Phase 1/2 Completed

Breast Neoplasms

NCT01769625 2017-08-09

Changes in Biomarkers Using Prostaglandin Inhibitors

Phase 1/2 Completed

Biomarker Change Linked to Breast Cancer

NCT00056082 2017-02-15

Celecoxib in Preventing Breast Cancer in At-Risk Premenopausal Women

Phase 2 Completed

Breast Neoplasms

NCT00045591 2017-01-11

Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer

Phase 2 Terminated

Breast Neoplasms

NCT00070057 2016-12-29

Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast Cancer

Phase 1 Completed

Breast Neoplasms

NCT01067989 2015-07-08

Low-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast Cancer

Phase 2 Terminated

Breast Neoplasms, Neoplasm Metastasis

NCT00201773 2015-06-30

Exemestane With Celecoxib as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast Cancer

Phase 2 Completed

22 enrolled 9 charts

Breast Neoplasms

NCT00135018 2012-05-24

Study on the Neoadjuvant Use of Chemotherapy and Celecoxib Therapy in Patients With Invasive Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT00525096 2011-06-30

Exemestane + Celecoxib vs Exemestane + Placebo in Metastatic Breast Cancer

Phase 3 Completed

Breast Neoplasms

NCT00101062 2011-06-08

Letrozole and Celecoxib in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

Phase 2 Terminated

Breast Neoplasms

NCT00328432 2008-09-17

A Study of Women With an Early Diagnosis of Breast Cancer, Taking Celecoxib Between the Biopsy and Lumpectomy/Mastectomy

Phase 1 Completed

Breast Neoplasms